» Articles » PMID: 314454

Recognition of Hapten-modified Cells in Vitro by Human T-lymphocytes

Overview
Journal J Clin Invest
Specialty General Medicine
Date 1979 Oct 1
PMID 314454
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Clearer definition of the recognitive structures of human T lymphocytes for antigens will be required to elucidate the molecular basis of diseases and immunological responses induced or regulated by normal or abnormal T-cell function. For this purpose we have investigated the cellular requirements for immune responses in vitro to trinitrophenyl-conjugated peripheral blood mononuclear cells. The responding cell was characterized as a T cell on the basis of rosetting with sheep erythrocytes. T-cell recognition of hapten in proliferative responses depended upon presentation of antigen in an appropriate stimulator-cell context. Neither autologous hapten-modified erythrocytes nor T cells restimulated responses of in vitro-primed lymphocytes. Moreover, hapten-conjugated non-T cells were more effective than modified unfractionated cells in restimulating proliferative responses. Both macrophages and non-T lymphocytes effectively restimulated hapten-conjugate responses.Cell-mixing experiments indicated that the failure of haptenated T cells to stimulate proliferative responses was not because of a lack of fresh macrophages; these experiments suggested instead that T cells do not express appropriate structures necessary to present haptenic determinants in an immunogenic form. Hapten-modified T cells, however, were capable of inducing primed lymphocytes to become efficient cytotoxic effector cells, indicating that T-cell recognitive units for stimulation of proliferative and cytotoxic responses are different. These data support the concept that for induction of proliferative responses, human T cells recognize conventional antigens in association with HLA-D-region-encoded Ia-like molecules.

Citing Articles

Antigen presentation to human T lymphocytes. I. Different requirements for stimulation by hapten-modified cells vs. cell sonicates.

Abramson S, Puck J, Rich R J Exp Med. 1981; 154(4):1005-15.

PMID: 6974758 PMC: 2186480. DOI: 10.1084/jem.154.4.1005.


Dendritic cells are accessory cells for the development of anti-trinitrophenyl cytotoxic T lymphocytes.

Nussenzweig M, Steinman R, Gutchinov B, COHN Z J Exp Med. 1980; 152(4):1070-84.

PMID: 6968335 PMC: 2185968. DOI: 10.1084/jem.152.4.1070.

References
1.
LAWRENCE H . Delayed sensitivity and homograft sensitivity. Annu Rev Med. 1960; 11:207-30. DOI: 10.1146/annurev.me.11.020160.001231. View

2.
Terasaki P, MCCLELLAND J . MICRODROPLET ASSAY OF HUMAN SERUM CYTOTOXINS. Nature. 1964; 204:998-1000. DOI: 10.1038/204998b0. View

3.
Biddison W, Shaw S, Nelson D . Virus specificity of human influenza virus-immune cytotoxic T cells. J Immunol. 1979; 122(2):660-4. View

4.
Thorsby E, Nousiainen H . In vitro sensitization of human T lymphocytes to hapten (TNP)-conjugated and non-treated autologous cells is restricted by self-HLA-D. Scand J Immunol. 1979; 9(2):183-92. DOI: 10.1111/j.1365-3083.1979.tb02721.x. View

5.
Seldin M, Rich R, DuPont B . Human immune responses to hapten-conjugated cells. II. The roles of autologous and allogeneic histocompatibility determinants in proliferative responses in vitro. J Immunol. 1979; 122(5):1828-33. View